Purpose Obstructive sleep apnea (OSA) is frequently treated with continuous positive airway
pressure (CPAP) or mandibular advancement devices (MADs). For various reasons, both …

Adherence to either continuous positive airway pressure (CPAP) or bilevel positive airway
pressure (BiPAP) therapy in patients with obstructive sleep apnea syndrome (OSAS) …

Chronic insomnia disorder, for our purposes, insomnia disorder (ID), is defined broadly as
difficulty in initiating or maintaining sleep that occurs at least 3 nights out of the week for 3 …

Study objective Excessive daytime sleepiness is common with obstructive sleep apnoea and
can persist despite efforts to optimise primary airway therapy. The literature lacks …

Obstructive Sleep Apnea Syndrome (OSAS) affects 13–33% of males and 6–9% of females
globally and poses significant treatment challenges, including poor adherence to …

People with obstructive sleep apnea (OSA) are a heterogeneous group. While many
succeed in the treatment of their OSA, many others struggle with therapy. Herein, we discuss …

Background: Insomnia is usually associated with mental and physical daytime impairment.
Zaleplon (Zp) is indicated in insomnia management but its limited aqueous solubility led to …

Obstructive sleep apnea (OSA) is characterized by repetitive airway closure, which can lead
to hypoxemia and sympathetic nervous system activation. This can result in significant …

Background Z-drugs are nonbenzodiazepine hypnotics used for sleep initiation and
maintenance; these drugs increase the risk of fall-related injuries in older adults. The …

Riittävän pitkä ja hyvälaatuinen uni on välttämätöntä ihmiselämälle. Unihäiriöt nostavat
usein yöllistä verenpainetta, ja ne lisäävät sydän-ja verisuonisairausten riskiä …